作者
Adrià Juanola,Ann T.,Koos de Wit,Kohilan Gananandan,Olivier Roux,Giacomo Zaccherini,Cesar Jiménez,Marta Tonon,Cristina Solé,C. Villaseca,Frank Erhard Uschner,Isabel Graupera,Elisa Pose,Maria José Moreta,Daniela Campion,Ulrich Beuers,Rajeshawar P Mookerjee,Claire Francoz,François Durand,Vı́ctor Vargas,Salvatore Piano,Sonia Alonso Sáenz De Oger,Jonel Trebicka,Wim Laleman,Sumeet K. Asrani,Germán Soriano,Carlo Alessandria,Miquel Serra‐Burriel,Manuel Morales‐Ruiz,Ferràn Torres,Andrew S. Allegretti,Aleksander Krag,Paolo Caraceni,Hugh Watson,Juan G. Abraldeṣ,Elsa Solà,Patrick S. Kamath,Rubén Hernáez,Pere Ginés
摘要
Patients with decompensated cirrhosis experience high mortality rates. Current prognostic scores, including the model for end-stage liver disease (MELD), may underperform in settings other than in those they were initially developed. Novel biomarkers have been proposed to improve prognostication accuracy and even to predict development of complications.
薰硝壤
不配.
Henry
浅尝离白
个性的紫菜
有人
Leonardi
寻道图强
iNk
Singularity
juziyaya
8R60d8
竹筏过海
pcr163
肯德鸭
咖啡豆
itsserene
乐乐乐乐乐乐
yufanhui
LY
皖公网安备34019202002308
